title: Aging and the neurovascular unit.
abstract: With the demonstration that acute recanalization of obstructed symptomatic cerebral arteries during ischemic stroke can result in substantial improvement in clinical outcome, the variability in clinical responses, and in hemorrhagic transformation, requires attention. This short review addresses the effect of aging and amyloid deposition disease on microvessel integrity, interactions within the neurovascular unit, cerebral tissue susceptibility to ischemic injury, and postischemic inflammation, and ultimately on the outcomes and safety of acute recanalization during ischemic stroke. Microvessels and neighboring neurons respond simultaneously to focal ischemia. The cellular components and matrix barriers of the neurovascular unit all respond to ischemia; however, their coordinate interactions are not understood. Furthermore, there is little known about the cell-cell and cell-matrix interactions within the unit, or about the effect of β-amyloid on microvessel responses during ischemia. These considerations indicate the need for a coordinated research effort to understand the origins of the variability in recanalization outcome.
authors.affiliation: Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA. grgdlzop@u.washington.edu
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: del Zoppo
mesh_terms: D000375:Aging / Q000502:physiology*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000254:growth & development* / Q000378:metabolism; D002545:Brain Ischemia / Q000453:epidemiology / Q000473:pathology; D016657:Cerebral Amyloid Angiopathy / Q000378:metabolism / Q000473:pathology; D002543:Cerebral Hemorrhage / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology; D002560:Cerebrovascular Circulation; D004198:Disease Susceptibility; D049030:Dystroglycans / Q000378:metabolism; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D005109:Extracellular Matrix / Q000378:metabolism; D016166:Free Radical Scavengers / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation; D045726:Metalloproteases / Q000378:metabolism; D008833:Microcirculation; D009457:Neuroglia / Q000378:metabolism; D009474:Neurons / Q000473:pathology; D010960:Plasminogen Activators / Q000627:therapeutic use; D015912:Thrombolytic Therapy
chemical_list: D016229:Amyloid beta-Peptides; C483081:DAG1 protein, human; D018691:Excitatory Amino Acid Antagonists; D016166:Free Radical Scavengers; D049030:Dystroglycans; D045726:Metalloproteases; D010960:Plasminogen Activators